Chloroquine and the fungal phagosome

Related Experiment Video

Updated: Oct 13, 2026

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
11:07

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans

Published on: December 19, 2014

S M Weber1, S M Levitz, T S Harrison

  • 1Evans Memorial Department of Clinical Research, Boston University School of Medicine, Massachusetts 02118, USA.

Current Opinion in Microbiology
|September 6, 2000
PubMed

Insights

The antimalarial drug chloroquine shows antifungal activity against Histoplasma capsulatum and Cryptococcus neoformans. Further clinical studies are needed to explore its potential as an adjuvant or prophylactic therapy for fungal diseases.

Area of Science:

  • Mycology
  • Pharmacology
  • Infectious Diseases

Background:

  • The antimalarial drug chloroquine is known to accumulate in macrophage phagolysosomes.
  • Fungal infections caused by Histoplasma capsulatum and Cryptococcus neoformans pose significant health risks.

Purpose of the Study:

  • To investigate the antifungal activity of chloroquine against Histoplasma capsulatum and Cryptococcus neoformans.
  • To elucidate the distinct mechanisms by which chloroquine exerts its antifungal effects.

Main Methods:

  • Experiments were conducted to assess the growth inhibition of H. capsulatum and C. neoformans in the presence of chloroquine.
  • Mechanisms of action, including pH-dependent iron deprivation and direct toxicity, were explored.

Main Results:

  • Chloroquine demonstrated potent antifungal activity against both H. capsulatum and C. neoformans.
  • Chloroquine inhibited H. capsulatum growth via pH-dependent iron deprivation.
  • Chloroquine exhibited direct toxicity towards C. neoformans.

Conclusions:

  • Chloroquine possesses significant antifungal properties against key pathogenic fungi.
  • Clinical trials are warranted to evaluate chloroquine as an adjuvant therapy for fungal diseases.
  • The broad-spectrum antimicrobial potential of chloroquine suggests its utility in prophylactic strategies.

More Related Videos

Investigating the Phagocytosis of Leishmania using Confocal Microscopy08:41

Investigating the Phagocytosis of Leishmania using Confocal Microscopy

Published on: July 29, 2021

High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays10:38

High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays

Published on: July 17, 2014

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Diversity of Protists II01:27

Diversity of Protists II

Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...